NYSE: UNH | Healthcare / Healthcare Plans / USA |
472.59 | +2.53 | +0.54% | Vol 3.48M | 1Y Perf -7.83% |
Mar 31st, 2023 16:00 DELAYED |
BID | 472.00 | ASK | 475.00 | ||
Open | 471.52 | Previous Close | 472.59 | ||
Pre-Market | - | After-Market | 481.02 | ||
- - | 8.43 1.78% |
Target Price | 598.30 | Analyst Rating | Strong Buy 1.45 | |
Potential % | 26.60 | Finscreener Ranking | ★★+ 46.48 | |
Insiders Trans % 3/6/12 mo. | -67/-60/-82 | Value Ranking | ★+ 43.35 | |
Insiders Value % 3/6/12 mo. | -100/-97/-99 | Growth Ranking | ★★★★ 57.60 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-97/-99 | Income Ranking | ★★ 40.10 | |
Price Range Ratio 52W % | 21.12 | Earnings Rating | Sell | |
Market Cap | 440.85B | Earnings Date | 14th Apr 2023 | |
Alpha | 0.01 | Standard Deviation | 0.07 | |
Beta | 0.77 |
Today's Price Range 470.10476.00 | 52W Range 449.70558.10 | 5 Year PE Ratio Range 13.1032.00 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -0.71% | ||
1 Month | -0.55% | ||
3 Months | -10.86% | ||
6 Months | -6.43% | ||
1 Year | -7.83% | ||
3 Years | 99.14% | ||
5 Years | 120.84% | ||
10 Years | 737.91% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 17.68 | |||
ROE last 12 Months | 24.35 | |||
ROA (5Y Avg) | 3.91 | |||
ROA last 12 Months | 7.76 | |||
ROC (5Y Avg) | 13.39 | |||
ROC last 12 Months | 17.37 | |||
Return on invested Capital Q | 4.51 | |||
Return on invested Capital Y | 3.77 | |||
Assets Turnover | 0.90 | |||
Receivables Turnover | 7.30 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
24.00 | ||||
6.13 | ||||
1.91 | ||||
13.70 | ||||
26.60 | ||||
35.66 | ||||
-22.84 | ||||
79.89 | ||||
463.97B | ||||
Forward PE | 19.16 | |||
PEG | 1.64 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.70 | ||||
0.80 | ||||
0.37 | ||||
0.62 | ||||
14.70 | ||||
Leverage Ratio | 3.10 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
23.70 | ||||
8.60 | ||||
9.70 | ||||
6.70 | ||||
6.55 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
240.20B | ||||
257.08 | ||||
7.28 | ||||
8.42 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.35 | ||||
6.60 | ||||
14.71 | ||||
17.23 | ||||
Payout ratio | 34.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2022 | 5.17 | 5.34 | 3.29 |
Q03 2022 | 5.45 | 5.79 | 6.24 |
Q02 2022 | 5.24 | 5.57 | 6.30 |
Q01 2022 | 5.40 | 5.49 | 1.67 |
Q04 2021 | 4.30 | 4.48 | 4.19 |
Q03 2021 | 4.41 | 4.52 | 2.49 |
Q02 2021 | 4.41 | 4.70 | 6.58 |
Q01 2021 | 4.42 | 5.31 | 20.14 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | 5.17 | -3.54 | Negative |
12/2022 FY | 22.02 | 0.73 | Positive |
3/2023 QR | 6.06 | -0.98 | Negative |
12/2023 FY | 24.84 | 0.40 | Positive |
Next Report Date | 14th Apr 2023 |
Estimated EPS Next Report | 6.25 |
Estimates Count | 10 |
EPS Growth Next 5 Years % | 14.60 |
Volume Overview | |
---|---|
Volume | 3.48M |
Shares Outstanding | 932.85K |
Shares Float | 934.55M |
Trades Count | 66.95K |
Dollar Volume | 1.64B |
Avg. Volume | 3.05M |
Avg. Weekly Volume | 2.74M |
Avg. Monthly Volume | 2.95M |
Avg. Quarterly Volume | 3.46M |
UnitedHealth Group Incorporated (DE) (NYSE: UNH) stock closed at 472.59 per share at the end of the most recent trading day (a 0.54% change compared to the prior day closing price) with a volume of 3.48M shares and market capitalization of 440.85B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 330000 people. UnitedHealth Group Incorporated (DE) CEO is Andrew P. Witty.
The one-year performance of UnitedHealth Group Incorporated (DE) stock is -7.83%, while year-to-date (YTD) performance is -10.86%. UNH stock has a five-year performance of 120.84%. Its 52-week range is between 449.7009 and 558.1, which gives UNH stock a 52-week price range ratio of 21.12%
UnitedHealth Group Incorporated (DE) currently has a PE ratio of 24.00, a price-to-book (PB) ratio of 6.13, a price-to-sale (PS) ratio of 1.91, a price to cashflow ratio of 13.70, a PEG ratio of 2.32, a ROA of 7.76%, a ROC of 17.37% and a ROE of 24.35%. The company’s profit margin is 6.55%, its EBITDA margin is 9.70%, and its revenue ttm is $240.20 Billion , which makes it $257.08 revenue per share.
Of the last four earnings reports from UnitedHealth Group Incorporated (DE), there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $6.25 for the next earnings report. UnitedHealth Group Incorporated (DE)’s next earnings report date is 14th Apr 2023.
The consensus rating of Wall Street analysts for UnitedHealth Group Incorporated (DE) is Strong Buy (1.45), with a target price of $598.3, which is +26.60% compared to the current price. The earnings rating for UnitedHealth Group Incorporated (DE) stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
UnitedHealth Group Incorporated (DE) has a dividend yield of 1.35% with a dividend per share of $6.60 and a payout ratio of 34.00%.
UnitedHealth Group Incorporated (DE) has a Sell technical analysis rating based on Technical Indicators (ADX : 8.05, ATR14 : 9.61, CCI20 : 13.84, Chaikin Money Flow : -0.08, MACD : -2.51, Money Flow Index : 54.27, ROC : 1.54, RSI : 47.68, STOCH (14,3) : 49.71, STOCH RSI : 0.44, UO : 46.08, Williams %R : -50.29), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of UnitedHealth Group Incorporated (DE) in the last 12-months were: Andrew P. Witty (Sold 11 376 shares of value $6 005 390 ), Dirk C. McMahon (Sold 14 715 shares of value $7 994 939 ), F. William McNabb (Buy at a value of $44 884), John F. Rex (Option Excercise at a value of $3 143 731), John F. Rex (Sold 13 183 shares of value $7 138 990 ), Richard T. Burke (Sold 7 500 shares of value $3 664 285 ), Stephen J. Hemsley (Option Excercise at a value of $5 698 522), Stephen J. Hemsley (Sold 99 312 shares of value $53 059 224 ), Thomas E. Roos (Sold 465 shares of value $252 201 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
UnitedHealth Group is the largest private health insurance provider in the United States, providing medical benefits to 48 million members across its U.S. and international businesses at the end of 2020. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
CEO: Andrew P. Witty
Telephone: +1 952 936-1300
Address: 9900 Bren Road East, Minnetonka 55343, MN, US
Number of employees: 330 000
Tue, 07 Mar 2023 10:50 GMT Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), UnitedHealth (UNH) and Haleon PLC Sponsored ADR (HLN)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.